John Henry and Rick Berke Launch STAT a Publication Dedicated to Health, Medicine and Life Sciences

Total Page:16

File Type:pdf, Size:1020Kb

John Henry and Rick Berke Launch STAT a Publication Dedicated to Health, Medicine and Life Sciences EMBARGOED UNTIL 12:00 A.M NOV. 4 2015 FOR IMMEDIATE RELEASE November 4, 2015 Contact: Kate Nocera/SKDKnickerbocker [email protected] / 202-464-6968 John Henry and Rick Berke Launch STAT A Publication Dedicated to Health, Medicine and Life Sciences November 4, 2015 — Boston — John W. Henry, owner of The Boston Globe and principal owner of the Boston Red Sox, and longtime reporter and editor Rick Berke today launched STAT, a national publication reporting from the frontiers of health, medicine and life sciences. The publication has assembled a news team of nearly 40 top journalists, as well as an engineering team, an advertising team, and a marketing team. Delivering fast, deep and tough-minded journalism, STAT will take readers inside science labs and hospitals, biotech boardrooms and political backrooms. It will publish breaking news, richly reported feature stories, investigative projects and multimedia presentations throughout the day at STATnews.com. “Over the next 20 years, some of the most important stories in the world are going to emerge in the life sciences arena. STAT has a tremendous opportunity to uncover vital issues that touch the lives of every human being,” Henry said. “We realized that there was no one doing what we aim to do: be the country’s go-to news source for the life sciences.” STAT is headquartered in Boston, with additional reporters in New York, San Francisco and Washington, and more to follow in other cities around the world. “I’m grateful to have the opportunity to hire dozens of the most talented reporters, writers and multimedia phenoms in the country to join our quest to create a news site with stories you won’t find anywhere else,” said Berke, a former assistant managing editor at The New York Times and executive editor at Politico. “We will take readers behind the scenes of the worlds of science and medicine and introduce them to patients and personalities who are driving a revolution in human health.” STAT reporters have wasted no time breaking news even before today’s launch. Initial stories, published through its sister publication, The Boston Globe, included an exclusive on Democratic presidential candidate Bernie Sanders rejecting a campaign donation from price-hiking pharmaceutical executive Martin Shkreli; a scoop on President Obama’s nominee to head the Food and Drug Administration pulling his name off several scientific papers that were critical of the agency; a fascinating deep dive into clinical trials in the age of social media; and an important examination of the shortcomings of precision medicine. STAT has also launched a fast-paced email newsletter, “Morning Rounds,” which has quickly become a must-read. The STAT editing team is led by three accomplished journalists: The managing editor for news, Stephanie Simon, has been a national reporter for The Los Angeles Times, The Wall Street Journal, and, most recently, Politico. The managing editor for enterprise, Gideon Gil, was the Boston Globe’s health and science editor. Jason Ukman, the senior news editor, was an editor at the Washington Post for 14 years. Gil and Ukman played important roles in editing Pulitzer Prize- winning stories for their organizations. STAT has developed a sleek website with an emphasis on its mobile version. It has also built out an extensive multimedia unit including animators, a data visualization editor and videographers. Led by New York Times veterans Jeffery DelViscio and Matthew Orr, the team will bring stories to visual life, creating everything from short, social-media-focused video explainers to mini- documentaries to interactive reader experiences. A strong lineup of regular features is also in the works: Carl Zimmer, STAT national correspondent and a New York Times columnist, will host a monthly video feature called “Science Happens” that will take viewers inside laboratories conducting cutting-edge biomedical research. Veteran pharmaceutical industry reporter Ed Silverman will revive his blog Pharmalot, last at The Wall Street Journal, and will write a weekly column. Sharon Begley, a nationally renowned science writer and formerly an editor at Newsweek, will puncture myths and question conventional wisdom in her column “Gut Check.” STAT will conduct monthly nationwide polling on health and medicine issues in partnership with Harvard’s T.H. Chan School of Public Health. In a new biweekly podcast, “Signal,” leading biotech reporters Meg Tirrell of CNBC and Luke Timmerman of the Timmerman Report will deliver a high-energy mix of news analysis, feature stories and interviews with movers and shakers in the biotech industry. A section called “First Opinion,” overseen by Patrick Skerrett, previously executive editor for Harvard Health Publications, will feature science, medical and financial experts weighing in on the news of the day. Ivan Oransky and Adam Marcus, of the popular site “Retraction Watch,” will write “The Watchdogs,” focusing on issues of misconduct, fraud and scientific integrity. In addition, the reporting staff includes former Politico reporter David Nather, a health policy expert who will lead the STAT Washington bureau; Helen Branswell, a renowned global health reporter who comes from The Canadian Press; enterprise reporter David Armstrong, who covered health care on the projects team for Bloomberg News and The Wall Street Journal; senior writer Bob Tedeschi, a longtime New York Times columnist who will write about patients and clinicians; Charles Piller, an award-winning investigative reporter for The Sacramento Bee and The Los Angeles Times; and Seth Mnookin, a contributing writer and prominent author. Other editors include Elie Dolgin, PhD in evolutionary genetics who was previously an associate editor at The Scientist and senior news editor at Nature Medicine; Lisa Raffensperger, a former web editor at Discover Magazine; and Tony Fong, previously a senior editor at GenomeWeb. Chief Revenue Officer Angus Macaulay, a veteran executive of publishing companies including Rodale, Hearst Magazines and Time, Inc., leads the business team. Michele Staats, the former head of integrated marketing at Massachusetts General Hospital, is the marketing director at STAT. Peter Bless, a 16-year veteran of scientific and healthcare advertising, is sales director. In addition to brand ads, the STAT business team will be developing sponsored content and native advertising intended for readers interested in health, medicine and life sciences. For more information please go to STATnews.com, or visit us on Facebook: https://www.facebook.com/STATnews, or Twitter: https://twitter.com/STATnews. .
Recommended publications
  • Periodicalspov.Pdf
    “Consider the Source” A Resource Guide to Liberal, Conservative and Nonpartisan Periodicals 30 East Lake Street ∙ Chicago, IL 60601 HWC Library – Room 501 312.553.5760 ver heard the saying “consider the source” in response to something that was questioned? Well, the same advice applies to what you read – consider the source. When conducting research, bear in mind that periodicals (journals, magazines, newspapers) may have varying points-of-view, biases, and/or E political leanings. Here are some questions to ask when considering using a periodical source: Is there a bias in the publication or is it non-partisan? Who is the sponsor (publisher or benefactor) of the publication? What is the agenda of the sponsor – to simply share information or to influence social or political change? Some publications have specific political perspectives and outright state what they are, as in Dissent Magazine (self-described as “a magazine of the left”) or National Review’s boost of, “we give you the right view and back it up.” Still, there are other publications that do not clearly state their political leanings; but over time have been deemed as left- or right-leaning based on such factors as the points- of-view of their opinion columnists, the make-up of their editorial staff, and/or their endorsements of politicians. Many newspapers fall into this rather opaque category. A good rule of thumb to use in determining whether a publication is liberal or conservative has been provided by Media Research Center’s L. Brent Bozell III: “if the paper never met a conservative cause it didn’t like, it’s conservative, and if it never met a liberal cause it didn’t like, it’s liberal.” Outlined in the following pages is an annotated listing of publications that have been categorized as conservative, liberal, non-partisan and religious.
    [Show full text]
  • Senate Vote on Trump Trial Signals an Acquittal Is Likely
    P2JW027000-6-A00100-17FFFF5178F ****** WEDNESDAY,JANUARY27, 2021 ~VOL. CCLXXVII NO.21 WSJ.com HHHH $4.00 DJIA 30937.04 g 22.96 0.1% NASDAQ 13626.06 g 0.1% STOXX 600 407.70 À 0.6% 10-YR. TREAS. unch , yield 1.039% OIL $52.61 g $0.16 GOLD $1,850.70 g $4.20 EURO $1.2162 YEN 103.62 In India, Farmers’ Protest Over New Law Turns Violent Microsoft What’s News SalesRise 17%Amid Business&Finance Covid-19 icrosoftposted record Mquarterly sales under- pinned by pandemic-fueled Pandemic demand forvideogaming and accelerated adoption of itscloud-computing services Demand for cloud during the health crisis. A1 services, videogaming Walgreens Bootsnamed Starbucks operating chief fuels earnings during Rosalind Brewerasits next work-from-home era CEO,making her the only Black woman leading a BY AARON TILLEY Fortune 500 company. A1 CK J&J said it expectstore- TO MicrosoftCorp. posted re- port pivotal resultsofalarge cord quarterly sales under- clinical trial of itsCovid-19 SHUTTERS pinned by pandemic-fueled de- vaccine by early next week, A/ mand forvideogaming and as the companyposted im- I/EP accelerated adoption of its AG proved quarterly sales. B1 TY cloud-computing services dur- ing the health crisis. GE booked $4.4billion Theremote-work erahas in fourth-quarter cash HARISH STREET CLASH: Indian farmers clash with police in New Delhi on Tuesday after breaking through barriers to escape po- been a boon for Microsoft. In flow,beating itsown pro- lice-approved routes for a tractor rally that coincided with a military parade celebrating India’s Republic Day.
    [Show full text]
  • The State of the News: Texas
    THE STATE OF THE NEWS: TEXAS GOOGLE’S NEGATIVE IMPACT ON THE JOURNALISM INDUSTRY #SaveJournalism #SaveJournalism EXECUTIVE SUMMARY Antitrust investigators are finally focusing on the anticompetitive practices of Google. Both the Department of Justice and a coalition of attorneys general from 48 states and the District of Columbia and Puerto Rico now have the tech behemoth squarely in their sights. Yet, while Google’s dominance of the digital advertising marketplace is certainly on the agenda of investigators, it is not clear that the needs of one of the primary victims of that dominance—the journalism industry—are being considered. That must change and change quickly because Google is destroying the business model of the journalism industry. As Google has come to dominate the digital advertising marketplace, it has siphoned off advertising revenue that used to go to news publishers. The numbers are staggering. News publishers’ advertising revenue is down by nearly 50 percent over $120B the last seven years, to $14.3 billion, $100B while Google’s has nearly tripled $80B to $116.3 billion. If ad revenue for $60B news publishers declines in the $40B next seven years at the same rate $20B as the last seven, there will be $0B practically no ad revenue left and the journalism industry will likely 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 disappear along with it. The revenue crisis has forced more than 1,700 newspapers to close or merge, the end of daily news coverage in 2,000 counties across the country, and the loss of nearly 40,000 jobs in America’s newsrooms.
    [Show full text]
  • A Look at the Legality Behind Daraprim's Price Spike Law360, New York (September 30, 2015, 12:15 PM ET)
    Portfolio Media. Inc. | 860 Broadway, 6th Floor | New York, NY 10003 | www.law360.com Phone: +1 646 783 7100 | Fax: +1 646 783 7161 | [email protected] A Look At The Legality Behind Daraprim's Price Spike Law360, New York (September 30, 2015, 12:15 PM ET) -- Turing Pharmaceuticals AG and its controversial CEO Martin Shkreli recently made headlines when Turing raised the price of its antiprotozal drug Daraprim (pyrimethamine) from $13.50 to $750 per tablet.[1] The price increase received significant media attention. Here, we evaluate Turing’s Daraprim price hike from a legal perspective, including an analysis of the mechanisms used to balance innovation and drug pricing in the U.S., and their degree of application, if any, to the drug’s recent price hike. Balancing Drug Prices and Innovation The United States has traditionally incentivized drug development innovation. Charles J. Andres Patents and the U.S. Food and Drug Administration's regulatory exclusivities allow an innovator to enjoy a protected U.S. market for a finite period of time. The market protection provided by these exclusivities helps innovators to recoup their research costs and make profits which, in part, are used to fund new research. Conversely, after the expiration of patents and market exclusivities, generic drugs can enter the marketplace. Generic drugs can ultimately cost 80 percent less than the branded drug.[2] Accordingly, U.S. laws (e.g., the Hatch-Waxman Act and Biologic Price Competition and Innovation Act of 2009) attempt to strike a balance by providing market incentives to innovators to bring new medicines to market in exchange for making generic drugs available to patients at a greatly reduced cost.
    [Show full text]
  • Notorious Turing CEO Martin Shkreli Arrested for Securities Fraud Like Share Tweet Share
    Job Seeker: Login Sign Up Employer: Login Post Jobs HOME NEWS JOBS CAREER RESOURCES HOTBEDS CAREER FAIRS EVENTS COMPANY PROFILES INVESTORS Search Life Sciences Jobs Job Title, Keyword or Company Name City, State, or Postal Code FIND JOBS > News | News By Subject | News by Disease | News By Date | Search News Get Our FREE Industry eNewsletter email: Notorious Turing CEO Martin Shkreli Arrested for Securities Fraud Like Share Tweet Share 12/17/2015 6:20:27 AM December 17, 2015 By Alex Keown, BioSpace.com Breaking News Staff NEW YORK – Martin Shkreli, the pharmaceutical industry’s so-called “bad boy,” has been arrested on charges of securities fraud related to his tenure as chief executive officer of Retrophin Inc. (RTRX) Shkreli, who became something of an industry pariah after increasing the price of a 65-year-old drug 5,000 percent, then lamenting the fact that he didn’t raise it even higher in order to increase profit, was arrested at his home this morning, Bloomberg reported. Shkreli is being charged with a misuse of company funds when he was CEO of that company. Prosecutors allege that Shkreli took company stock and used it to pay off personal debts. Additionally, Shkreli is charged with playing shell games with his former hedge fund, MSMB Capital Management, which lost millions of investor’s dollars, Bloomberg said. In January, Shkreli came under investigation by U.S. prosecutors for possible securities violations and from the U.S. Securities and Exchange Commission for the distribution of stock without letting shareholders know. An internal probe conducted by Retrophin and filed with the Securities and Exchange Commission on Feb.
    [Show full text]
  • Attorney General Herring Files Suit Against Martin
    SSearch Search ... Commonwealth of Virginia Office of the Attorney General Mark Herring 202 North Ninth Street Attorney General Richmond, Virginia 23219 For media inquiries only, contact: Charlotte Gomer, Press Secretary Phone: (804)786-1022 Mobile: (804) 512-2552 Email: [email protected] ATTORNEY GENERAL HERRING FILES SUIT AGAINST MARTIN SHKRELI AND VYERA PHARMACEUTICALS ~ Lawsuit seeks repayment of illegally obtained profits, lifetime ban on Shkreli working in pharmaceutical industry ~ RICHMOND (April 14, 2020) – Attorney General Mark R. Herring today joined a multistate lawsuit filed earlier this year against Vyera Pharmaceuticals, previously Turing Pharmaceuticals, and two of its former CEOs, including Martin Shkreli, for stifling competition to protect the exorbitant, monopolistic pricing of the drug Daraprim. Daraprim (pyrimethamine) is used to treat the parasitic disease toxoplasmosis, and despite Vyera Pharmaceuticals being the only FDA-approved source of the medication, Shkreli and Vyera raised the price of the drug by more than 4,000 percent overnight to $750 per pill, after purchasing the rights to Daraprim in August 2015. “Vyera Pharmaceuticals and Martin Shkreli made unconscionable decisions to maintain their monopoly on Daraprim and make as much money as possible,” said Attorney General Herring. “Because of their greed, Americans who couldn’t afford the exorbitant price of this drug were forced to make difficult, potentially life- threatening treatment decisions. Drug companies and their executives must be held accountable when they place profits over human lives.” Attorney General Herrring is one of six attorneys general today joining the lawsuit against Vyera and Shkreli that was originally filed by New York Attorney General Letitia James and the Federal Trade Commission (FTC) in January.
    [Show full text]
  • In the for the Fourth Circuit
    06-2140 In the United States Court of Appeals For the Fourth... Circuit CACI PREMIR TECHNOLOGY, INC., and CACI INTERNATIONAL INC., Plaintif-Appellants v. RAI RHODES and PIQUANT, LLC d//a Air America Radio, Defendants-Appellees, ON APPEAL FROM TI UNITED STATES DISTRCT COURT FOR THE EASTERN DISTRICT OF VIRGINIA ALEXANDRIA DIVISION BRIEF OF AMICI CURIAE ALM MEDIA, INC., THE ASSOCIATED PRESS, COX ENTERPRISES, INC., DOW JONES & COMPANY, INC., GANNETT CO., INC., THE HEART CORPORATION, LANDMAR COMMUNICATIONS, INC., MAGAZINE PUBLISHERS OF AMERICA, INC., NBC UNIVRSAL, INC., THE NEW YORK TIMES COMPAN, NEWSPAPER ASSOCIATION OF AMRICA, NEWSWEEK, INC., THE RADIO-TELEVISION NEWS DIRECTORS ASSOCIATION, THE REPORTERS COMMITTEE FOR FREEDOM OF THE PRESS, TIME INC., and THE WASHINGTON POST, IN SUPPORT OF APPELLEES Jack M. Weiss Theodore B. Olson Joshua Wilkenfe1d Theodore J. Boutrous, Jr. Laura M. Leitner GIBSON, DUN & CRUTCHER LLP GIBSON, DUN & CRUTCHER LLP Attorneysfor Amici Curiae Attorneys for Amici Curiae 1050 Connecticut Avenue N.W. 200 Park Avenue Washington, DC 20036 New York, New York 10166 (202) 955-8500 (212) 351-4000 OF COUNSEL: NBC UNIVERSAL, INC. ALM MEDIA, INC. Craig Bloom Allison C. Hoffman 30 Rockefeller Plaza Fabio B. Bertoni New York, NY 10112 345 Park Avenue South New York, NY 10010 THE NEW YORK TIMES COMPANY David E. McGraw THE ASSOCIATED PRESS 229 West 43rd Street David H. Tomlin New York, NY 10036 450 W. 33rd Street New York, NY 10001 NEWSPAPER ASSOCIA nON OF AMERICA René P. Milam Cox ENTERPRISES, INC. 4401 Wilson Boulevard, Suite 900 Andrew Merdek Arlington, Virginia 22203 Dale Cohen 6205 Peachtree Dunwoody Road NEWSWEEK, INC.
    [Show full text]
  • Outline of Selected SEC Enforcement Actions, Division of Enforcement (October 2016)
    © Practising Law Institute CORPORATE LAW AND PRACTICE Course Handbook Series Number B-2303 The SEC Speaks in 2017 Co-Chairs David W. Grim Marc Wyatt To order this book, call (800) 260-4PLI or fax us at (800) 321-0093. Ask our Customer Service Department for PLI Order Number 186008, Dept. BAV5. Practising Law Institute 1177 Avenue of the Americas New York, New York 10036 © Practising Law Institute Enforcement Panel and Workshop 41 © Practising Law Institute 42 © Practising Law Institute 3 Outline of Selected SEC Enforcement Actions, Division of Enforcement (October 2016) Prepared by: Sherry A. Peyton Research Specialist Seth Groveunder Intern The SEC (SEC), as a matter of policy, disclaims responsibility for any private publication or statement by any of its employees. The views expressed herein are those of the authors and do not necessarily reflect the views of the SEC or of the authors’ colleagues upon the staff of the SEC. Parts of this outline have been used in other publications. If you find this article helpful, you can learn more about the subject by going to www.pli.edu to view the on demand program or segment for which it was written. 43 © Practising Law Institute 44 © Practising Law Institute Table of Contents ACTIONS INVOLVING BROKER-DEALERS, INVESTMENT ADVISERS AND INVESTMENT COMPANIES AND OTHER REGULATED ENTITIES ......................................................................... 9 In the Matter of Merrill Lynch, Pierce, Fenner & Smith Incorporated ........................................................................................ 11 In the Matter of Merrill Lynch, Pierce, Fenner & Smith Incorporated Professional Clearing Corp. ........................................... 13 In the Matter of William Tirrell ............................................................. 15 SEC v. Ash Narayan, et al. ................................................................. 19 In the Matter of Apex Fund Services (US), Inc.
    [Show full text]
  • The Boston Bombing Psy-Op
    Before reading on please read my pdf ‘THE BOSTON BOMBING PSY- OP’. http://sharonkilby.co.uk/site/THE_BOSTON_BOMBING_PSY- OP.php Super shill Chris Spivey [or more accurately the people who write his articles] knows all too well how the general public are prevented from getting anywhere near the real truth, and thus becoming a real threat to the ‘PTB’ [Illuminati/Masonic mafia]. He spells it out in his ‘Debunking Diana’ article http://chrisspivey.org/the-night-of-the-living-dead/ The content of that article BTW takes outrageous bollox to new levels! I’m not even going to go there. I’m only interested in how we are being mind controlled – by the likes of Spiv, and countless other COINTELPRO turds. This is what Spivey says [I’ve changed some of his wording slightly to reflect more of the truth]: “ALL of the many, many conspiracy theories arising from Diana’s death [of which there are far more than your usual psy-op due to how popular she was] was the doing of the Masonic controlled cointelpro agents, thus keeping the pretend investigative-journalists [mainstream and ‘alternative’] working to divert you from ever finding the right rabbit hole to burrow down. And since the huge number of anomalies in the official version of events ensured that enough in- fighting would occur over how the said anomalies were interpreted, the mainstream viewing public [since everyone else is a tin foil hat] were, in general, happy to go along with the official version of events.” “You see, by leaving room for conspiracy theories (which are red herrings designed to send those investigating the official narrative down the wrong path), The-Powers-That-Be are able to keep the vast majority believing their fiction, whilst keeping the rest - the blanket labelled “conspiracy theorists/nutters” away from finding out the real truth.” “..
    [Show full text]
  • The Importance of Newspapers in Scholarly Research Highlights from a Study from the Oxford Internet Institute on the Scholarly Impacts of Newspapers
    The Importance of Newspapers in Scholarly Research Highlights from a study from the Oxford Internet Institute on the scholarly impacts of newspapers About this study Newspapers are an important part of the Eric T. Meyer, currently the Dean of the School of Information academic publishing landscape at University of Texas, Austin, The data in this report conducted in partnership between ProQuest and formerly a Professor of Social Informatics and Director and the Oxford Internet Institute reveals a clear story: newspapers of Graduate Studies at Oxford are an important part of the academic publishing landscape, and Internet Institute, conducted the their use is growing, both in absolute numbers and when measured data collection and analysis. by the proportion of academic publications that cite one of these Four newspaper titles were well-known titles. selected for evaluation and analysis in this report: This study examines the frequency of newspaper citations in scholarly • The New York Times journal articles and also reveals the disciplines in which scholars most • The Wall Street Journal often use newspapers as a source for academic research. • The Washington Post This summary highlights four key findings. The complete study • The Guardian is available here: Scopus was used as the source for the data examined. Meyer, Eric T., The Scholarly Impacts of Newspapers: The Guardian, Washington Post, Wall Street Journal, and New York Times (May 2, 2018). Available at SSRN: https://ssrn.com/abstract=3194632 or http://dx.doi.org/10.2139/ssrn.3194632 Get a Free Trial of Titles Featured in this Study www.proquest.com/go/newstitles-scholarlyimpact Four Key Findings ONE: The use of newspapers in research is on the rise The chart in Figure 1 indicates the number of published scholarly articles that include citations of the newspaper titles included in this study.
    [Show full text]
  • The Signal and the Noise
    nieman spring 2013 Vol. 67 no. 1 Nieman Reports The Nieman Foundation for Journalism REPOR Harvard University One Francis Avenue T s Cambridge, Massachusetts 02138 Nieman VOL Reports . 67 67 . To promoTe and elevaTe The sTandards of journalism n o. 1 spring 2013 o. T he signal and T he noise The SigNal aNd The NoiSe hall journalism and the future of crowdsourced reporting Carroll after the Boston marathon murdoch bombings ALSO IN THIS ISSUE Fallout for rupert mudoch from the U.K. tabloid scandal T HE Former U.s. poet laureate NIEMAN donald hall schools journalists FOUNDA Associated press executive editor T Kathleen Carroll on “having it all” ion a T HARVARD PLUS Murrey Marder’s watchdog legacy UNIVERSI Why political cartoonists pick fights Business journalism’s many metaphors TY conTEnts Residents and journalists gather around a police officer after the arrest of the Boston Marathon bombing suspect BIG IDEAS BIG CELEBRATION Please join us to celebrate 75 years of fellowship, share stories, and listen to big thinkers, including Robert Caro, Jill Lepore, Nicco Mele, and Joe Sexton, at the Nieman Foundation for Journalism’s 75th Anniversary Reunion Weekend SEPTEMBER 27–29 niEMan REPorts The Nieman FouNdatioN FoR Journalism at hARvARd UniversiTy voL. 67 No. 1 SPRiNg 2013 www.niemanreports.org PuBliShER Ann Marie Lipinski Copyright 2013 by the President and Fellows of harvard College. Please address all subscription correspondence to: one Francis Avenue, Cambridge, MA 02138-2098 EdiToR James geary Periodicals postage paid at and change of address information to: Boston, Massachusetts and additional entries. SEnioR EdiToR Jan gardner P.o.
    [Show full text]
  • {PDF EPUB} Pinstriped Summers Memories of Yankee Seasons Past by Dick Lally Lally, Richard
    Read Ebook {PDF EPUB} Pinstriped Summers Memories of Yankee Seasons Past by Dick Lally Lally, Richard. PERSONAL: Married Barbara Bauer (a writer; divorced). ADDRESSES: Agent —c/o Author Mail, Random House/Crown, 1745 Broadway, New York, NY 10019. CAREER: Sportswriter. WRITINGS: (With Bill Lee) The Bartender's Guide to Baseball , Warner Books (New York, NY), 1981. (With Bill Lee) The Wrong Stuff , Viking (New York, NY), 1984. Pinstriped Summers: Memories of Yankee Seasons Past , Arbor House (New York, NY), 1985. Chicago Clubs (collectors edition), Bonanza Books (New York, NY), 1991. Boston Red Sox (collectors edition), Bonanza Books (New York, NY), 1991. (With Joe Morgan) Baseball for Dummies , foreword by Sparky Anderson, IDG Books Worldwide (Foster City, IA), 1998. (With Joe Morgan) Long Balls, No Strikes: What Baseball Must Do to Keep the Good Times Rolling , Crown (New York, NY), 1999. Bombers: An Oral History of the New York Yankees , Crown (New York, NY), 2002. (With Bill Lee) Have Glove, Will Travel: The Adventures of a Baseball Vagabond , Crown (New York, NY), 2005. SIDELIGHTS: Sports writer Richard Lally focusses much of his efforts on his main passion: baseball. After collaborating with former pro player Bill Lee on Lee's autobiography, The Wrong Stuff , Lally wrote Pinstriped Summers: Memories of Yankee Seasons Past , a book that focuses on the team's history from the time the Columbia Broadcasting System (CBS) bought the team in 1965 until the 1982 season. During this period, the Yankees experienced great success, winning four American League pennants and two World Series. They also experience "down" years, including a last-place finish in 1966.
    [Show full text]